Zobrazeno 1 - 10
of 193
pro vyhledávání: '"Elisabetta Munzone"'
Autor:
Alberto Zambelli, Marina Cazzaniga, Nicla La Verde, Elisabetta Munzone, Ippazio Cosimo Antonazzo, Lorenzo Giovanni Mantovani, Serena Di Cosimo, Anna Mancuso, Daniele Generali, Paolo Angelo Cortesi
Publikováno v:
Breast, Vol 71, Iss , Pp 113-121 (2023)
Introduction: Clinical trials confirmed the beneficial effects of adding pertuzumab (P) to the combination of trastuzumab-chemotherapy (TC) in the (neo)adjuvant setting of high-risk HER2-positive early breast cancer (HER2+BC). We evaluated the clinic
Externí odkaz:
https://doaj.org/article/0aa2d78e2920415082d58a11e2d80f2f
Autor:
Marianna Masiero, Chiara Filipponi, Elisa Fragale, Silvia Francesca Maria Pizzoli, Elisabetta Munzone, Alessandra Milani, Luca Guido, Vittorio Guardamagna, Sara Marceglia, Roberto Prandin, Marco Prenassi, Annamaria Caruso, Vania Manzelli, Chiara Savino, Costanza Conti, Federica Rizzi, Alice Casalino, Giulia Candiani, Francesca Memini, Luca Chiveri, Andrea Luigi Vitali, Massimo Corbo, Roberto Grasso, Florence Didier, Roberta Ferrucci, Gabriella Pravettoni
Publikováno v:
JMIR Formative Research, Vol 8, p e51021 (2024)
BackgroundChronic pain is one of the most common and critical long-term effects of breast cancer. Digital health technologies enhance the management of chronic pain by monitoring physical and psychological health status and supporting pain self-manag
Externí odkaz:
https://doaj.org/article/a446879e863e4bdd9edbe45dc26cda08
Autor:
Marianna Masiero, Gea Elena Spada, Virginia Sanchini, Elisabetta Munzone, Ricardo Pietrobon, Lucas Teixeira, Mirtha Valencia, Aline Machiavelli, Elisa Fragale, Massimo Pezzolato, Gabriella Pravettoni
Publikováno v:
JMIR Research Protocols, Vol 13, p e55928 (2024)
Externí odkaz:
https://doaj.org/article/4ac54d6526ea4e3cbd504cad23cb3fe9
Autor:
Marianna Masiero, Gea Elena Spada, Virginia Sanchini, Elisabetta Munzone, Ricardo Pietrobon, Lucas Teixeira, Mirtha Valencia, Aline Machiavelli, Elisa Fragale, Massimo Pezzolato, Gabriella Pravettoni
Publikováno v:
JMIR Research Protocols, Vol 12, p e48852 (2023)
BackgroundAdherence to oral anticancer treatments is critical in the disease trajectory of patients with breast cancer. Given the impact of nonadherence on clinical outcomes and the associated economic burden for the health care system, finding ways
Externí odkaz:
https://doaj.org/article/27932501e85749948a19bd71e855f7e7
Autor:
Konstantinos Venetis, Carlo Pescia, Giulia Cursano, Chiara Frascarelli, Eltjona Mane, Elisa De Camilli, Elisabetta Munzone, Silvia Dellapasqua, Carmen Criscitiello, Giuseppe Curigliano, Elena Guerini Rocco, Nicola Fusco
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 11, p 5717 (2024)
Multigene prognostic genomic assays have become indispensable in managing early breast cancer (EBC), offering crucial information for risk stratification and guiding adjuvant treatment strategies in conjunction with traditional clinicopathological pa
Externí odkaz:
https://doaj.org/article/8542f68d726f4ac5bec6035dcad0a537
Autor:
Marianna Masiero, Chiara Filipponi, Silvia Francesca Maria Pizzoli, Elisabetta Munzone, Luca Guido, Vittorio Andrea Guardamagna, Sara Marceglia, Annamaria Caruso, Roberto Prandin, Marco Prenassi, Vania Manzelli, Chiara Savino, Costanza Conti, Federica Rizzi, Alice Casalino, Giulia Candiani, Francesca Memini, Luca Chiveri, Andrea Luigi Vitali, Massimo Corbo, Alessandra Milani, Roberto Grasso, Silvia Traversoni, Elisa Fragale, Florence Didier, Gabriella Pravettoni
Publikováno v:
JMIR Research Protocols, Vol 12, p e41216 (2023)
BackgroundChronic pain (CP) and its management are critical issues in the care pathway of patients with breast cancer. Considering the complexity of CP experience in cancer, the international scientific community has advocated identifying cutting-edg
Externí odkaz:
https://doaj.org/article/595f4f39713d40e5bef88540d1143d8d
Autor:
Luca Licata, Deborah Cosentini, Rita De Sanctis, Monica Iorfida, Elena Rota Caremoli, Andrea Vingiani, Edda Lucia Simoncini, Giancarlo Pruneri, Elisabetta Munzone, Giampaolo Bianchini, Alberto Zambelli, Carlo Tondini
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
The increasing understanding of breast cancer biology has provided the basis for the development of multigene signatures aimed to improve the capability of clinicians to assess patients’ prognostication and risk stratification. Incorporating these
Externí odkaz:
https://doaj.org/article/6a67d1afaa084dd89c84e592f33d434c
Autor:
Sherene Loi, Roberto Salgado, Sylvia Adams, Giancarlo Pruneri, Prudence A. Francis, Magali Lacroix-Triki, Heikki Joensuu, Maria Vittoria Dieci, Sunil Badve, Sandra Demaria, Robert Gray, Elisabetta Munzone, Damien Drubay, Jerome Lemonnier, Christos Sotiriou, Pirkko Liisa Kellokumpu-Lehtinen, Andrea Vingiani, Kathryn Gray, Fabrice André, Carsten Denkert, Martine Piccart, Elvire Roblin, Stefan Michiels
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-4 (2022)
Abstract The importance of integrating biomarkers into the TNM staging has been emphasized in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging system. In a pooled analysis of 2148 TNBC-patients in the adjuvant setting, TILs ar
Externí odkaz:
https://doaj.org/article/1d7e042990e84c619c98e8ac72964f2e
Autor:
Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, Claudio Vernieri, Antonino Belfiore, Luca Agnelli, Gianpaolo Dagrada, Diana Ivanoiu, Giuseppina Bonizzi, Elisabetta Munzone, Luana Lippolis, Martina Dameri, Francesco Ravera, Marco Colleoni, Giuseppe Viale, Luca Magnani, Alberto Ballestrero, Gabriele Zoppoli, Giancarlo Pruneri
Publikováno v:
PLoS Genetics, Vol 19, Iss 1, p e1010563 (2023)
BackgroundPrevious studies have provided a comprehensive picture of genomic alterations in primary and metastatic Hormone Receptor (HR)-positive, Human Epidermal growth factor Receptor 2 (HER2)-negative breast cancer (HR+ HER2- BC). However, the evol
Externí odkaz:
https://doaj.org/article/14b422e7ad2742c09e052fbd82eff010
Autor:
Silvia Dellapasqua, Pamela Trillo Aliaga, Elisabetta Munzone, Vincenzo Bagnardi, Eleonora Pagan, Emilia Montagna, Giuseppe Cancello, Raffaella Ghisini, Claudia Sangalli, Mara Negri, Manuelita Mazza, Monica Iorfida, Anna Cardillo, Angela Sciandivasci, Nadia Bianco, Ana Paula De Maio, Monica Milano, Giuseppe Maria Campennì, Loredana Sansonno, Giuseppe Viale, Anna Morra, Maria Cristina Leonardi, Viviana Galimberti, Paolo Veronesi, Marco Colleoni
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 5167-5178 (2021)
Background: Adjuvant chemotherapy for Luminal B-like breast cancers usually includes anthracycline-based regimens. However, some patients are reluctant to receive chemotherapy because of side-effects, especially alopecia, and ask for a “less intens
Externí odkaz:
https://doaj.org/article/01c8698cc532419a944449afa4337d24